Revenue Growth Rates : DCIs data indicate about 8% year-over-year growth from 2023 to 2024 in specialty dispensing, while total pharmacy revenues grew 10% from 2024 to 2025 (reaching $751B), heavily driven by GLP-1 medications ( [5] )
J Mol Model
Vomiting : In some cases, nausea may escalate to vomiting, requiring medical attention if it becomes severe or persistent
SPL UNCLASSIFIED SECTION Hypersensitivity Reactions In a pool of Study 1 and 2, immediate hypersensitivity reactions (within one day after drug administration) occurred in 2.1% of ZEPBOUND-treated patients compared to 0.4% of placebo-treated patients, while non-immediate hypersensitivity reactions occurred in 3.5% of ZEPBOUND-treated patients compared to 2.7% of placebo-treated patients
The EY-Parthenon analysis shows a potential reduction in sales of as much as 3% across the salty, sweet and confectionary snack categories, likely impeding growth opportunities for manufacturers
Diabetes Management Consult Top Diabetologists View All Frequently Asked Questions How long does it take for Mounjaro to start working